The Office of Technology Licensing was established in 1970 to transfer technologies developed at Stanford. Find out more about OTL's history, mission, staff, and statistics.

Login to TechFinder » 

If your browser is not displaying images correctly, try clearing your cookies and cache to solve the problem.

Login and Registration
You are not logged into the OTL TechFinder web site. If you are already registered, please login. Otherwise, registration is free and entitles you to receive emails and correspondence about new technology releases.

Would you like to find out about other ways to engage with Stanford?
If so, please visit http://corporate.stanford.edu/.

Achieving B-Cell Lymphoma Growth Modulation and Enhanced Tumor Resistance Using Idiotype/Cytokine Conjugates

Cancer treatments aimed at mobilizing host immunity must not only identify tumor antigens but improve the efficacy of antigen presentation. Researchers at Stanford recognized the importance of local cytokine action in increasing antigen presentation. This...
more information »

Autoimmune Demyelination Treatment with Nogo Fragments

Researchers in Prof. Lawrence Steinman’s laboratory have developed a patented therapeutic compound that could be used to treat multiple sclerosis and other autoimmune demyelinating conditions. This technology is based on the finding that Nogo (a protei...
more information »

What is TechFinder?
By clicking the links above you can search the database for opportunities and submit requests for additional information. TechFinder contains text and images. TechFinder is updated within minutes of any changes made at Stanford's Office of Technology Licensing.